Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Acambis" found in our extensive corporate database of over 50,000 company records.
Acambis recognises the value of highly focused marketing efforts and is initially targeting the world's single largest vaccine market – the US – to maximise the return on our investment. In 2003, we acquired a North American vaccine sales, promotion and distribution company, Berna Products Corporation (BPC). BPC has the exclusive North American sales and distribution rights to the world's only...
Acambis is a biopharmaceutical company discovering, developing and manufacturing vaccines to prevent and treat infectious diseases. Employing some 160 people, it is based in Cambridge, UK, and Cambridge, Massachusetts. It currently has 11 products in development, of which six are currently undergoing clinical trials, and technology platforms that provide the basis for the development of new produc...
Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bioscience industries. Ten are still private, two have been merged, three have been bought by public companies, two have been sold for cash and one is listed on the public markets. Prior to the formation...
Implicit Bioscience Pty Ltd is an immunology-focused drug development company headquartered in Brisbane, Australia; Implicit's US subsidiary, Implicit Bioscience, Inc., is located on the San Francisco Peninsula. Established in early 2004 by a group of Australian and US industry veterans, the company has assembled a team with significant industry experience across the full range of drug development...